Filing Details

Accession Number:
0001179110-20-007163
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-10 07:54:02
Reporting Period:
2020-06-09
Accepted Time:
2020-06-10 07:54:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
744218 Celldex Therapeutics Inc. CLDX In Vitro & In Vivo Diagnostic Substances (2835) 133191702
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1429933 S Anthony Marucci C/O Celldex Therapeutics, Inc.
53 Frontage Road
Hampton NJ 08827
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2020-06-09 15,000 $3.06 19,438 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Includes 1,103 shares of Common Stock acquired under the Company's 2004 Employee Stock Purchase Plan.